MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04484cam a22004337i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
19042212 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240831135357.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160404s2016 enka b 000 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2016937843 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128030721 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0128030720 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)ocn938383554 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
YDXCP |
| Language of cataloging |
eng |
| Transcribing agency |
FEU-NRMF MEDICAL LIBRARY |
| Description conventions |
rda |
| Modifying agency |
BTCTA |
| -- |
BDX |
| -- |
CDX |
| -- |
OCLCO |
| -- |
OCLCF |
| -- |
OCLCQ |
| -- |
SHH |
| -- |
DRB |
| -- |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
lccopycat |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RA 1231.M52 .Aa77 2016 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.9/253 |
| Edition number |
23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Aaseth, Jan, |
| Relator term |
author |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Chelation therapy in the treatment of metal intoxication / |
| Statement of responsibility, etc. |
Jan Aaseth, Guido Criponi, Ole Andersen. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
London, UK ; |
| -- |
San Diego, CA, USA : |
| Name of publisher, distributor, etc. |
Academic Press is an imprint of Elsevier, |
| Date of publication, distribution, etc. |
2016. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvi, 371 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
24 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Cover; Title Page; Copyright Page; Contents; Contributors; Preface; List of Abbreviations; Chapter 1 -- General Chemistry of Metal Toxicity and Basis for Metal Complexation; 1.1 -- General chemistry of metals; 1.2 -- Essential and nonessential elements; 1.3 -- Effects of toxic exposure of an essential or nonessential metal; 1.3.1 -- Basic Concepts in Chemical Toxicity Testing; 1.3.2 -- Exposure Patterns and Mechanisms of Metal Toxicity; 1.3.3 -- Gastrointestinal Effects of Metal Exposure; 1.3.4 -- Respiratory Effects of Metal Exposure; 1.3.5 -- Hepatic and Renal Effects. |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1.3.6 -- Effects on the Nervous System1.3.7 -- Hematological Effects; 1.3.8 -- Cardiovascular Effects; 1.3.9 -- Metal Allergies; 1.3.10 -- Carcinogenic Effects; 1.4 -- Basis for metal complex formation with endogenous and exogenous ligands; 1.5 -- Endogenous complexing and detoxification compounds; 1.5.1 -- Albumin; 1.5.2 -- Transferrin and Ferritin; 1.5.3 -- Glutathione; 1.5.4 -- Metallothionein; 1.5.5 -- Selenoproteins; 1.6 -- Conclusions; References; Chapter 2 -- Chelating Agents as Therapeutic Compounds-Basic Principles; 2.1 -- Chemical and biological principles for in vivo chelation; 2.1.1 -- Stability. |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
2.1.2 -- Selectivity2.1.3 -- Kinetic Aspects of Chelation; 2.1.4 -- Absorption and Bioavailability of Chelating Agents; 2.2 -- Chelating agents: chemistry, kinetics, and toxicology; 2.2.1 -- BAL, DMPS, DMSA; 2.2.2 -- D-penicillamine; 2.2.3 -- Triethylenetetramine; 2.2.4 -- Deferoxamine, Deferiprone, and Deferasirox; 2.2.5 -- EDTA and DTPA; 2.2.6 -- Prussian Blue; References; Chapter 3 -- Diagnosis and Evaluation of Metal Poisonings and Chelation Therapy; 3.1 -- Introduction; 3.2 -- History of symptoms and exposure; 3.3 -- Clinical findings; 3.4 -- Genetic disorders with systemic metal accumulation. |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
3.5 -- Toxicological analyses3.6 -- Biochemical measurements; 3.7 -- Physiological, radiological, and ultrasonographic investigations; References; Chapter 4 -- Chelation Treatment During Acute and Chronic Metal Overexposures-Experimental and Clinical Studies; 4.1 -- Introduction; 4.2 -- Aluminum; 4.2.1 -- Selected Representative Animal Studies; 4.2.2 -- Selected Representative Clinical Studies; 4.2.3 -- Conclusions; 4.3 -- Antimony; 4.3.1 -- Animal Experiments; 4.3.2 -- Clinical Cases; 4.3.3 -- Conclusion; 4.4 -- Arsenic; 4.4.1 -- Selected Animal Experiments; 4.4.2 -- Clinical Studies. |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
4.4.3 -- Discussion and Conclusion4.5 -- Beryllium; 4.5.1 -- Experimental Chelation Studies; 4.5.2 -- Clinical Experience; 4.5.3 -- Conclusion; 4.6 -- Bismuth; 4.6.1 -- Animal Chelation Studies; 4.6.2 -- Clinical Chelation Studies; 4.6.3 -- Conclusion; 4.7 -- Cadmium; 4.7.1 -- Animal Chelation Experiments; 4.7.2 -- Clinical Chelation Studies; 4.7.3 -- Conclusion; 4.8 -- Chromium; 4.8.1 -- Animal Experimental Studies; 4.8.2 -- Clinical Cases; 4.8.3 -- Conclusion; 4.9 -- Cobalt; 4.9.1 -- Chelation, Animal Experiments; 4.9.2 -- Chelation, Clinical Studies; 4.9.3 -- Conclusion; 4.10 -- Copper. |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
4.10.1 -- Animal Chelation Studies. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Department of Pathology & Laboratory Diagnosis |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chelation therapy. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Source of heading or term |
Metals |
| General subdivision |
Toxicology |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Criponi, Guido, |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Andersen, Ole, |
| Relator term |
author |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Enable Ebook |
Yes |
| Link text |
Click here to view TABLE OF CONTENTS and INDEX |
| Uniform Resource Identifier |
<a href="https://library.feu-nrmf.ph/cgi-bin/koha/opac-retrieve-file.pl?id=65e4b21a4b35a20c5fd36a4dec4580c6">https://library.feu-nrmf.ph/cgi-bin/koha/opac-retrieve-file.pl?id=65e4b21a4b35a20c5fd36a4dec4580c6</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books Overnight |
